• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY C TOTAL BILIRUBIN REAGENT KIT; DIAZO COLORIMETRY, BILIRUBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY C TOTAL BILIRUBIN REAGENT KIT; DIAZO COLORIMETRY, BILIRUBIN Back to Search Results
Model Number 04V5131
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/17/2020
Event Type  malfunction  
Manufacturer Narrative
Patient identifier: (b)(6).All available patient information is included.Additional patient details are not available.An evaluation is in process.A follow up report will be submitted when the evaluation is complete.
 
Event Description
The customer reported false elevated alinity c total bilirubin results for neonates compared to the gasometer (b)(4), radiometer-spectrophotometry).The customer provided the following for four patients: sid: (b)(6): initial = 15.53 mg/dl, repeat 15.96 mg/dl, and gasometer = 11.5 mg/dl; sid: (b)(6): initial = 15.28 mg/dl, repeats = 14.92 mg/dl, 13.25 mg/dl(dil 1:5), 12.43 mg/dl (dil 1:10), & gasometer 11.6 mg/dl; sid: (b)(6): initial = 14.42 mg/dl, and gasometer = 11.2 mg/dl; sid: (b)(6): initial = 15.42 mg/dl, and gasometer = 11.9 mg/dl.There was no reported impact to patient management there was no reported impact to patient management.
 
Manufacturer Narrative
The evaluation of the customer¿s issue included a search for similar complaints, ticket trending review, labeling review, device history record review.A review of tickets determined that there is normal complaint activity for lot 57809uq07.Trending review determined no trend for falsely elevated results for the product.Return testing was not completed as returns were not available.The customer reports that all alinity total bilirubin quality control results are within expected ranges; this appears to be a patient sample specific event.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on all available information no systemic issue or product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY C TOTAL BILIRUBIN REAGENT KIT
Type of Device
DIAZO COLORIMETRY, BILIRUBIN
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10979262
MDR Text Key220706243
Report Number3002809144-2020-01173
Device Sequence Number1
Product Code CIG
UDI-Device Identifier00380740158422
UDI-Public00380740158422
Combination Product (y/n)N
PMA/PMN Number
K121985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/09/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/30/2021
Device Model Number04V5131
Device Catalogue Number04V51-31
Device Lot Number57809UQ07
Was Device Available for Evaluation? No
Date Manufacturer Received12/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY C PROCESSING MODU, 03R67-01, AC03189; ALNTY C PROCESSING MODU, 03R67-01, AC03189
-
-